Amryt Pharma Share Discussion Threads

[papillon] 21/5/2019 09:25

Yes, I agree, diamondstar.

[purple11] 21/5/2019 09:07

commiseration paps...I did try and say.....

[digadee] 21/5/2019 08:56

good to see you back on here diamondstar, the news today in my opinion is huge and i for one did not see it coming at all. Excellent work by the board to clinch this. Finally we will be listed on the nasdaq, better appreciation of the drug sector in the states. The company did well to keep this news quite.

"Enlarged group to be re-admitted to AIM and Euronext Growth on closing with a planned dual-listing on NASDAQ"

[diamondstar1] 21/5/2019 08:45

Paps - I think this is the reason for the spike in Amryt share price a few days ago, rather than a share tip.

[diamondstar1] 21/5/2019 08:40

Yes, I did suspect that Amryt was going to inlicense Myalepta for the EU market, but they have effectively killed 2 birds with one stone with the acquisition of Aegerion -they now have a presence in North America and can market episalvan (once approved) through these channels. Having the Myalepta global market is icing on the cake.
I still have very high hopes for episalvan (AP101) in EB. I know that efficacy is modest i.e. about 10% improvement in primary endpoint. But this is acceptable, especially if you are the first to market. A stroke of Irish luck here - that Zorblisa failed in Ph 3. Look what happened to GSK’s SLE drug Benlysta (belimumab), which is a success with sales increasing year-on-year. Efficacy was modest, but GSK received FDA approval in 2011, as the first drug approved for SLE in over 50 years. So, all Amryt have to do is meet the primary endpoint for EASE Ph III. Amryt do not have to show fantastic efficacy, around 20-30%. The scenario would be different, if there were other drugs already approved for EB.

[waterloo01] 21/5/2019 07:42

Good to see AMYT get up to £85m upside on AP101 (given current market cap is £26m)

[bermudashorts] 21/5/2019 07:33

Wow! Am pretty sure someone here made the connection with Myalepta, was it Diamondstar? Well called whoever it was.

[waterloo01] 21/5/2019 07:17

Need to absorb. Shares suspended so time to consider but looks like a transformative move

[bazworth] 21/5/2019 07:09

Didn’t see that coming!

[purple11] 15/5/2019 15:24

see how TRP and i3E get along once drilling starts in a couple of months....theyre big winners pappy...tuck a few away...you could get yourself a new lawnmower for the yard when they come in.gl


p.s I knew you couldn't resist a little peek at my posts...

[papillon] 15/5/2019 15:12

Not too long ago purple11 tipped I3E and TRP. LOL. Not set the world alight have they, purple11, since you tipped them? I3E has performed especially poorly. A right "doggy" in fact, purple11. How much are you down? That's if you ever held them!

Never take any notice of pumpers and dumpers, like purple11, when they tip shares. I won't tip shares on message boards. I definitely wouldn't tip AMYT to anyone. It's a gamble I'm prepared to take, but it's definitely not for widows and orphans. It's just a risky, speculative, punt as far as I'm concerned.

[papillon] 15/5/2019 14:45

purple11 15 May '19 - 14:36 - 4447 of 4448 (Filtered)

[papillon] 15/5/2019 14:39

Back to reality. I reckon that the reason for Monday & Tuesday's rise was a tip. I remember around 20 years ago I subscribed for a short period of time in a tip sheet called The Small Company Sharewatch. I just looked on the web and I was surprised to see it still exists!


I'm not saying they tipped AMYT, but there are a lot of tip sheets out there and it's possible one of them tipped AMYT. That could explain today's fall because that often happens soon after a share has risen on a tip.


Well the rise was nice as long as it lasted and the share price is still up marginally on last week.

[purple11] 15/5/2019 14:36

O dear pappy this doesn't look v good.

hope its not a bulltrap.

[bazworth] 15/5/2019 14:35

We seem to have gone into reverse whooooooosh!

[papillon] 15/5/2019 10:47

positivityNicholas 15 May '19 - 07:50 - 4444 of 4444 (Filtered)

[positivitynicholas] 15/5/2019 07:50

Thanks for the insight into how to read a basic chart. You must give out more lessons and teach us more Warren Buffet. Yo

[papillon] 14/5/2019 20:36

A 3 year AMYT log chart. Arrow shows when bearish Death Cross occurred.


free stock charts from uk.advfn.com



free stock charts from uk.advfn.com

[papillon] 14/5/2019 17:49

I'll post a couple of charts tonight. Going by the EMA's AMYT was a sell when the 50 day EMA went below an already descending 200 day EMA (A Death Cross, a bearish signal) in October 2017 and hasn't been a buy ever since then because the 50 day EMA hasn't gone above the 200 day EMA since then (A Golden Cross is a bullish signal and occurs when the 50 day EMA rises above an already rising 200 day EMA). So as I mentioned back in October 2017 AMYT shares should have been sold then (in fact they should have been sold in September 2017 when the placing was announced). Of course I ignored my own advice! LOL.

[papillon] 14/5/2019 17:23

Bronxville
Posts: 959
Opinion:
No Opinion
Price:
13.55
RE: Candid after a reread?
Today 10:32
Maybe not sure..
But surely future investors in the Venn Life/Open Orphan tieup will look at Cathal Friel's double dealing
at Amryt (and Fastnet) as a precedent for investing in that venture.
It's only money I guess..


>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>


Well Shareprophets (via their HotStockRockets tipping site) are evidently fans of VENN/OpenOrphan because they have tipped it. Here's what ShareProphets says today:

Venn Life Sciences – transformative acquisition
By HotStockRockets
Venn Life Sciences (VENN) has served up 2018 results which, predictably, were a bit of a kitchen sink affair. But that is not the real news. This is the RTO of Open Orphan, which will be transformational. Ahead of that the shares will be suspended...

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

I can't post anymore because I don't subscribe to ShareProphets, or HotStockRockets. I wouldn't get too excited though because they said the same when AMYT RTO'd into FAST and that tip hasn't been profitable for those who piled in when AMYT listed (it went to the mid 30's on the morning of the first day of trading. Ouch!)

[papillon] 14/5/2019 10:36

Shares invariably gravitate towards their 200 day EMA. The AMYT 200 day EMA is currently at 15.1p, but falling. I wonder if the shares have been tipped?

[volsung] 14/5/2019 09:49

Plenty of interest volume-wise

[bazworth] 14/5/2019 08:22

Should have said I was bored earlier, we seem to have some interest!

[papillon] 14/5/2019 00:05

free stock charts from uk.advfn.com